{"result": "(\"entity\"<|>TUMORES DE CABEZA Y CUELLO<|>EVENT<|>Tumors of the head and neck are medical conditions that can lead to severe swallowing difficulties, necessitating nutritional artificial therapy.)\n##\n(\"entity\"<|>TUMORES DEL APARATO DIGESTIVO<|>EVENT<|>Tumors of the digestive system, such as those in the esophagus and stomach, can cause issues with swallowing and may require nutritional artificial therapy.)\n##\n(\"entity\"<|>CIRUGÍA OTORRINOLARINGOLÓGICA<|>EVENT<|>Otorhinolaryngological surgery can result in complications that affect swallowing, leading to the need for nutritional artificial therapy.)\n##\n(\"entity\"<|>ENFERMEDADES NEUROLÓGICAS<|>EVENT<|>Neurological diseases can cause severe swallowing difficulties, requiring patients to receive nutritional artificial therapy.)\n##\n(\"entity\"<|>ACCIDENTES CEREBROVASCULARES<|>EVENT<|>Cerebrovascular accidents can lead to impairments in swallowing, necessitating nutritional artificial therapy for affected patients.)\n##\n(\"entity\"<|>TUMORES CEREBRALES<|>EVENT<|>Brain tumors can impact swallowing ability, making nutritional artificial therapy necessary for some patients.)\n##\n(\"entity\"<|>PARÁLISIS CEREBRAL<|>EVENT<|>Cerebral palsy is a condition that can result in swallowing difficulties, often requiring nutritional artificial therapy.)\n##\n(\"entity\"<|>COMA NEUROLÓGICO<|>EVENT<|>Neurological coma can prevent normal eating, leading to the need for nutritional artificial therapy.)\n##\n(\"entity\"<|>SÍNDROMES DE MALABSORCIÓN SEVERA<|>EVENT<|>Severe malabsorption syndromes can necessitate nutritional artificial therapy to ensure adequate nutrient intake.)\n##\n(\"entity\"<|>ENFERMEDADES NEUROLÓGICAS SUBSIDIARIAS<|>EVENT<|>Neurological diseases that can be treated with ketogenic diets may also require nutritional artificial therapy in some cases.)\n##\n(\"entity\"<|>ALERGIA O INTOLERANCIA A LAS PROTEÍNAS DE LECHE DE VACA<|>EVENT<|>Allergy or intolerance to cow's milk proteins in infants can lead to nutritional challenges, requiring nutritional artificial therapy.)\n##\n(\"entity\"<|>PACIENTES DESNUTRIDOS<|>PERSON<|>Malnourished patients may require nutritional artificial therapy before undergoing major scheduled surgeries or transplants.)\n##\n(\"entity\"<|>ENCEFALOPATÍA HEPÁTICA CRÓNICA<|>EVENT<|>Chronic hepatic encephalopathy can lead to dietary protein intolerance, necessitating nutritional artificial therapy.)\n##\n(\"relationship\"<|>TUMORES DE CABEZA Y CUELLO<|>NUTRICIÓN ARTIFICIAL<|>Tumors of the head and neck can lead to swallowing difficulties, making nutritional artificial therapy necessary for affected patients.<|>8)\n##\n(\"relationship\"<|>TUMORES DEL APARATO DIGESTIVO<|>NUTRICIÓN ARTIFICIAL<|>Digestive system tumors can impair swallowing, requiring nutritional artificial therapy for proper nutrition.<|>8)\n##\n(\"relationship\"<|>CIRUGÍA OTORRINOLARINGOLÓGICA<|>NUTRICIÓN ARTIFICIAL<|>Otorhinolaryngological surgery may result in swallowing issues, necessitating nutritional artificial therapy.<|>8)\n##\n(\"relationship\"<|>ENFERMEDADES NEUROLÓGICAS<|>NUTRICIÓN ARTIFICIAL<|>Neurological diseases can cause severe swallowing difficulties, leading to the need for nutritional artificial therapy.<|>8)\n##\n(\"relationship\"<|>ACCIDENTES CEREBROVASCULARES<|>NUTRICIÓN ARTIFICIAL<|>Cerebrovascular accidents can impair swallowing, making nutritional artificial therapy necessary for recovery.<|>8)\n##\n(\"relationship\"<|>TUMORES CEREBRALES<|>NUTRICIÓN ARTIFICIAL<|>Brain tumors can affect swallowing ability, requiring nutritional artificial therapy for affected patients.<|>8)\n##\n(\"relationship\"<|>PARÁLISIS CEREBRAL<|>NUTRICIÓN ARTIFICIAL<|>Cerebral palsy can lead to swallowing difficulties, necessitating nutritional artificial therapy.<|>8)\n##\n(\"relationship\"<|>COMA NEUROLÓGICO<|>NUTRICIÓN ARTIFICIAL<|>Neurological coma can prevent normal eating, leading to the need for nutritional artificial therapy.<|>8)\n##\n(\"relationship\"<|>SÍNDROMES DE MALABSORCIÓN SEVERA<|>NUTRICIÓN ARTIFICIAL<|>Severe malabsorption syndromes may require nutritional artificial therapy to ensure adequate nutrient intake.<|>8)\n##\n(\"relationship\"<|>ENFERMEDADES NEUROLÓGICAS SUBSIDIARIAS<|>NUTRICIÓN ARTIFICIAL<|>Neurological diseases that can be treated with ketogenic diets may also require nutritional artificial therapy in some cases.<|>8)\n##\n(\"relationship\"<|>ALERGIA O INTOLERANCIA A LAS PROTEÍNAS DE LECHE DE VACA<|>NUTRICIÓN ARTIFICIAL<|>Allergy or intolerance to cow's milk proteins can lead to nutritional challenges, requiring nutritional artificial therapy.<|>8)\n##\n(\"relationship\"<|>PACIENTES DESNUTRIDOS<|>NUTRICIÓN ARTIFICIAL<|>Malnourished patients may require nutritional artificial therapy before undergoing major scheduled surgeries or transplants.<|>8)\n##\n(\"relationship\"<|>ENCEFALOPATÍA HEPÁTICA CRÓNICA<|>NUTRICIÓN ARTIFICIAL<|>Chronic hepatic encephalopathy can lead to dietary protein intolerance, necessitating nutritional artificial therapy.<|>8)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: a la conservación o mejora de la esperanza de vida, o a la eliminación o disminución del dolor y el sufrimiento. También deben aportar una mejora, en términos de seguridad, eficacia, efectividad, eficiencia o utilidad demostrada, respecto a otras alternativas.\n\nPrescripción y dispensación: en España, existen importantes diferencias en la prescripción y dispensación de la NED entre las distintas comunidades autónomas (tabla 3). Así, mientras que en unas comunidades autónomas se puede prescribir cualquiera de las fórmulas financiadas por el SNS, otras como Galicia han establecido su propio catálogo de fórmulas enterales, restringiendo el número de fórmulas aprobadas para financiación.\n\nLa dispensación de la NED se realiza en la mayoría de las comunidades en las oficinas de farmacia extrahospitalarias, precisando tanto de receta médica como de visado de inspección farmacéutica, con algunas excepciones como las de Cataluña y Galicia¹. En ambas comunidades la dispensación de los productos de NED se realiza a través de las farmacias hospitalarias. Sin embargo, en Cataluña la distribución posterior en algunos hospitales se hace directamente al domicilio del paciente a través de servicios de catering, mediante acuerdos con la industria farmacéutica².\n\nRespecto a la dispensación del material fungible, está recogido en la normativa que debe ser gratuita, pero se realiza de forma desigual entre comunidades, ya que no está regulada. En general, se administra desde el hospital o los centros de atención primaria, salvo en Cataluña, donde los servicios de farmacia han llegado a acuerdos con la industria farmacéutica para coordinar su entrega directa en el domicilio del paciente³.\n---\nTema 60. Nutrición artificial domiciliaria 939\n\n## Tabla 2. Situaciones clínicas que justifican la financiación de la nutrición artificial domiciliaria (NAD).\n\n### A. Alteraciones mecánicas de la deglución o del tránsito, que cursan con afagia o disfagia severa y precisan sonda\n\nA.1 Tumores de cabeza y cuello\nA.2 Tumores del aparato digestivo (esófago, estómago)\nA.3 Cirugía otorrinolaringológica (ORL) y maxilofacial\nA.4 Estenosis esofágica no tumoral\n\n### B. Trastornos neuromotores que impidan la deglución o el tránsito y que precisan sonda\n\nB.1 Enfermedades neurológicas que cursan con afagia o disfagia severa:\n   B.1.1 Esclerosis múltiple\n   B.1.2 Esclerosis lateral amiotrófica\n   B.1.3 Síndromes miasteniformes\n   B.1.4 Síndrome de Guillain-Barré\n   B.1.5 Secuelas de enfermedades infecciosas o traumáticas del sistema nervioso central\n   B.1.6 Retraso mental severo\n   B.1.7 Procesos degenerativos severos del sistema nervioso central\nB.2 Accidentes cerebrovasculares\nB.3 Tumores cerebrales\nB.4 Parálisis cerebral\nB.5 Coma neurológico\nB.6 Trastornos severos de la motilidad intestinal: pseudoobstrucción intestinal, gastroparesia diabética\n\n### C. Requerimientos especiales de energía y/o nutrientes\n\nC.1 Síndromes de malabsorción severa:\n   C.1.1 Síndrome de intestino corto severo\n   C.1.2 Diarrea intratable de origen autoinmune\n   C.1.3 Linfoma\n   C.1.4 Esteatorrea postgastrectomía\n   C.1.5 Carcinoma de páncreas\n   C.1.6 Resección amplia pancreática\n   C.1.7 Insuficiencia vascular mesentérica\n   C.1.8 Amiloidosis\n   C.1.9 Esclerodermia\n   C.1.10 Enteritis eosinofílica\nC.2 Enfermedades neurológicas subsidiarias de ser tratadas con dietas cetogénicas:\n   C.2.1 Epilepsia refractaria en niños\n   C.2.2 Deficiencia del transportador tipo I de la glucosa\n   C.2.3 Deficiencia del complejo de la piruvato-deshidrogenasa\nC.3 Alergia o intolerancia diagnosticada a las proteínas de leche de vaca en lactantes, hasta dos años si existe\n    compromiso nutricional\nC.4 Pacientes desnutridos que van a ser sometidos a cirugía mayor programada o trasplantes\nC.5 Pacientes con encefalopatía hepática crónica con intolerancia a las proteínas de la dieta\nC.6 Pacientes con adrenoleucod\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>ESPAÑA<|>GEO<|>Spain is a country in Europe with various autonomous communities that have different regulations regarding the prescription and dispensing of NED (nutritional artificial therapy).)\n##\n(\"entity\"<|>GALICIA<|>GEO<|>Galicia is an autonomous community in Spain that has established its own catalog of enteral formulas, restricting the number of formulas approved for funding.)\n##\n(\"entity\"<|>CATALUÑA<|>GEO<|>Cataluña is an autonomous community in Spain where the dispensing of NED products is done through hospital pharmacies and sometimes delivered directly to patients' homes through catering services.)\n##\n(\"entity\"<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>EVENT<|>Nutritional artificial therapy at home is a medical treatment that provides nutrition to patients who cannot eat normally, often requiring specific regulations for prescription and dispensing.)\n##\n(\"entity\"<|>NUTRICIÓN ARTIFICIAL<|>EVENT<|>Nutritional artificial therapy refers to the provision of nutrients through means other than oral intake, often necessary for patients with severe swallowing difficulties or specific medical conditions.)\n##\n(\"relationship\"<|>GALICIA<|>ESPAÑA<|>Galicia is an autonomous community within Spain that has specific regulations regarding NED, highlighting the differences in healthcare practices across the country.<|>7)\n##\n(\"relationship\"<|>CATALUÑA<|>ESPAÑA<|>Cataluña is another autonomous community in Spain with its own regulations for the dispensing of NED, indicating regional variations in healthcare practices.<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>NUTRICIÓN ARTIFICIAL<|>Nutritional artificial therapy at home is a specific application of nutritional artificial therapy, focusing on providing nutrition to patients in their homes.<|>8)\n<|COMPLETE|>"}]}